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Abstract
Purpose—Given the importance of family history in the early detection and prevention of type 2 
diabetes, we quantified the public health impact of reported family health history on diagnosed 
diabetes (DD), undiagnosed diabetes (UD), and prediabetes (PD) in the United States.
Methods—We used population data from the National Health Examination and Nutrition Survey 
2009 to 2014 to measure the association of reported family history of diabetes with DD, UD, and 
PD.
Results—Using polytomous logistic regression and multivariable adjustment, family history 
prevalence ratios were 4.27 (CI: 3.57, 5.12) for DD, 2.03 (CI: 1.56, 2.63) for UD, and 1.26 (CI: 
1.09, 1.44) for PD. In the United States, we estimate that 10.1 million DD cases, 1.4 million UD 
cases, and 3.9 million PD cases can be attributed to having a family history of diabetes.
Conclusions—These findings confirm that family history of diabetes has a major public health 
impact on diabetes in the United States. In spite of the recent interest and focus on genomics and 
precision medicine, family health history continues to be an integral component of public health 
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campaigns to identify persons at high risk for developing type 2 diabetes and early detection of 
diabetes to prevent or delay complications.
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Introduction
Type 2 diabetes is a major public health problem in the United States and globally. In 
2011-2012, among adults aged 20 years or older in the United States, the prevalence of 
diagnosed diabetes (DD), undiagnosed diabetes (UD), and prediabetes (PD) based on 
hemoglobin A1C or fasting plasma glucose were 9.2%, 3.1%, and 36.5% respectively.1 The 
prevalence of diabetes including UD in the United States has been projected to increase to 
between one in five and one in three adults by 20502. Along with overweight, physical 
inactivity, increasing age, high blood pressure, and minority race/ ethnicity groups, family 
history of diabetes has long been known to be an important risk factor for the occurrence of 
type 2 diabetes.3 While there are a few genetic disorders associated with the risk of type 2 
diabetes4, the cause of most type 2 diabetes is multifactorial involving the interaction of 
many genes (polygenic inheritance) and environmental/ behavioral risk factors5.
In addition to being a risk factor for type 2 diabetes itself, family history of diabetes also 
seems to be positively associated with risk awareness and behaviors that reduce risk of type 
2 diabetes.6 There is also evidence that including family history of diabetes in screening 
algorithms also improves the detection of previously UD.7,8 This association may also exist 
for PD. A study based on a population of European origin conducted in Germany found that 
having at least one first degree relative with diabetes was significantly associated with PD 
(odds ratio (OR)=1.4; 95% CI 1.27-1.54) and remained significant after adjusting for sex, 
age and body mass index (BMI) (adjusted OR (aOR)=1.3; 95% CI 1.14-1.40).9 In spite of 
the recent explosion in the discovery of numerous genetic variants associated with type 2 
diabetes, most associations have small effect sizes and do not account for the effect of family 
history as an independent risk factor for type 2 diabetes. Family history of diabetes reflects 
not only the contribution of genetic factors but also environmental, social, behavioral, 
nutritional and other potentially modifiable risk factors that are shared among relatives.
3,10,11
CDC and partners have made a concerted effort to educate the general public about the 
importance of collecting family health history for diabetes and other common chronic 
diseases using systematic free online tools.12,13 After a decade of such efforts, a recent 
national survey found that most people do not actively collect family health history, even 
though the vast majority believe it is important for their own health.14 It is also important to 
note that information available about the accuracy of such data is sparse. As far as we are 
aware, only one small study of 10 people with and 10 people without diabetes, conducted in 
the mid-1980s, has examined accuracy of family history of diabetes. According to this study, 
family history of diabetes agreed completely with that given by respective relatives in a 
follow-up interview.15 Among Hispanics, having a family history of diabetes was associated 
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with increased reported screening, but a similar association was not seen among non-
Hispanic whites.15
Given the importance of family history in the early detection and prevention of diabetes, we 
sought, using a nationally representative sample of the US Population (National Health and 
Nutrition Examination Survey (NHANES) 2009-2014) to quantify the national prevalence of 
reported family health history of diabetes and its contribution not only to DD but as 
importantly to PD and UD. We were interested in identifying the independent contributions 
of family history to the burden of DD, UD, and PD in the United States. In addition, we 
were interested in identifying variations in reported diabetes across subsets of the population 
(e.g. age, race/ethnicity, sex) and impact of family history on the identification of people at 
risk for developing type 2 diabetes.
Materials and Methods
NHANES is a series of surveys using stratified, multistage probability samples designed to 
provide assessments on the health and nutrition status of the civilian, noninstitutionalized 
US population. NHANES is conducted by the CDC's National Center for Health Statistics 
(NCHS) and has continuously collected data based on personal interviews and physical 
examination of survey participants in two year cycles since 1999. The present study included 
samples of adults aged ≥20 years in the cycles 2009-2010, 2011-2012, and 2013-2014. Some 
population subgroups were oversampled to increase the reliability and precision of estimates 
of health outcomes for these groups. Sample weights were adjusted to take in to account 
nonresponse, oversampling, and post-stratification. Detailed description of the NHANES 
sample design is available elsewhere (https://wwwn.cdc.gov/nchs/data/series/sr02_162.pdf). 
Participants complete an in-home interview for basic demographic and health information 
along with a scheduled visit to a mobile examination center for physical examination and 
laboratory testing. Written informed consent was obtained from each participant for both 
parts of the survey and all protocols were approved by the research ethics review boards of 
the NCHS. The response rates for the surveys ranged from 68.5% to 77.3%.16 . Pregnant 
women were excluded due to the effect of pregnancy on glucose measurement.
Definition of DD, UD, PD, and reported family history of diabetes
If a participant reported that they had ever been diagnosed with diabetes by a doctor or other 
health professional other than during pregnancy, we defined that person as having DD. 
Participants with a hemoglobin A1C level of ≥ 6.5% or a fasting plasma glucose (FPG) level 
of ≥ 126 mg/dL who reported no previous diagnosis of diabetes were defined as having UD.
1
 Participants with a hemoglobin A1C level of between 5.7% and 6.4% or a FPG level of 
between 100 mg/dL and 125 mg/dl who reported no previous diagnosis of diabetes were 
defined as having PD.1 To ensure that glucose values we used were consistent with earlier 
NHANES data, we corrected the measured FPG values using the equation recommended by 
NCHS, 0.9835*(FPG-1.139).17,18 Participants were asked whether any of their close 
biological (blood) relatives, including father, mother, sisters or brothers, were ever told by a 
health professional that they had diabetes. We defined participants as having a reported 
family history of diabetes if they responded “yes” to this question. Further information on 
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family history of diabetes is not available in NHANES 2009-2014 to do a more 
comprehensive analysis.
Statistical analysis
We partitioned the US population into PD, UD, DD, and none of these conditions. We used a 
polytomous logistic regression model to measure the association between the conditions and 
reported family history of diabetes by treating those with none of the conditions as the 
referent group. We included other risk factors in the model: age group (20-39, 40-59, ≥ 60 
years), sex, race/ ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, others), BMI 
(< 25, 25-30, ≥ 30 kg/m2), hypertension (≥ 140/90 / < 140/90 mm Hg), and leisure time 
physical activity (yes/ no). We defined participants as physically active if they had met the 
Healthy People 2010 objective of moderate- or vigorous-intensity physical activity.19 The 
risk factors selected were based on the recommendation of the American Diabetes 
Association.20 We also included income to poverty ratio (< 1/ ≥ 1) and education (< high 
school/ ≥ high school) in the model as indicators of socio-economic status. There were no 
significant interactions between family history and other risk factors and these terms were 
excluded from the final model. The interactions were tested by including all the interaction 
terms in the model and also including one interaction term at a time in the model.
Next, we estimated the weighted prevalence of DD and evaluated the association between 
DD and family history of diabetes for the US population and for the subgroups of the 
populations with the risk factors given above using logistic regression models. For example, 
for the population aged 20-39 years, we estimated the prevalence of DD, 95% confidence 
interval, and the OR for family history of diabetes adjusted for all the risk factors except for 
age. We extended this analysis for UD for the populations without DD and for PD for the 
populations without DD or UD. We only report significant (p < 0.05) ORs.
In case-control and cohort studies, measures of associations are usually reported as ORs and 
risk ratios. In cross-sectional studies, when prevalent cases are included, the OR may also be 
mentioned as the prevalence OR; instead of the risk ratio, the prevalence ratio is calculated. 
For associations between family history of diabetes and DD, UD, or PD having a significant 
OR, we estimated the population attributable fraction (PAF) for family history of diabetes 
using the formula, PAF = G(R − 1)G(R − 1) + 1 , where G is the prevalence of family history of diabetes 
in the population and R is the prevalence ratio. For DD and UD, we used OR as an 
approximate estimate for prevalence ratio. Since the prevalence of PD is relatively large (> 
10%), the approximate estimate of prevalence ratio was obtained from ORs, using the 
formula, prevalence ratio = OR(1 − p0) + OR ∗ p0
, where p0 is the prevalence of PD in the 
population that do not have a family history of diabetes.21 Next, we calculated the number of 
cases impacted by family history of diabetes in the DD, UD, and PD populations by 
multiplying PAF and the number of cases with each condition. To calculate the total number 
of cases with each condition by age group, sex, and race/ ethnicity categories, we used the 
distribution of the civilian noninstitutionalized US population obtained from the Census 
Bureau's Current Population Survey (CPS) as recommended by NCHS.16 We multiplied the 
average population size for the three survey cycles by the prevalence of each condition. For 
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populations defined by other risk factors, we calculated the product of the average US 
population size, the prevalence of the risk factor, and the prevalence of each condition. 
Bonferroni correction was used to determine the significance levels for pair-wise 
comparison tests of prevalence of family history of diabetes between groups.
The survey data were analyzed using SURVEYFREQ and SURVEYLOGISTIC procedures 
in SAS V 9.3 (SAS Institute, Cary, North Carolina) that takes into account the complex 
survey design of the NHANES, and the sample weights were adjusted for pooling three 
cycles of NHANES data.
Results
The study sample consisted of 8,796 non-pregnant adult respondents that included 2,149 DD 
cases, 612 UD cases, and 2,719 PD cases. Table 1 gives the crude prevalence of reported 
family history of diabetes for the US population, by age group, sex, race /ethnicity, and 
populations with other risk factors for type 2 diabetes. The prevalence of reported family 
history of diabetes in the US population age 20 years or over was 36.70% (95% CI: 35.05, 
38.26). The prevalence of reported family history of diabetes was significantly higher among 
females (estimate- 38.72%, (CI: 36.71, 40.73)) compared to males (estimate- 34.47%, (CI: 
32.57, 36.36)). By race/ ethnicity groups, the non-Hispanic black population had the highest 
prevalence of family history of diabetes, an estimate of 48.92% (CI: 45.92, 51.91). The 
relative disparities in the prevalence of family history of diabetes for non-Hispanic black and 
Hispanic populations (estimate- 41.11% (CI: 37.68, 44.54)) compared to non-Hispanic white 
population (estimate- 33.61%, (CI: 31.82, 35.40)) were 45.50% and 22.31% respectively. 
The prevalence of family history of diabetes increased with BMI (estimate- 44.30%, (CI: 
41.68, 46.92), in the highest group). Populations with less than high school education 
(estimate- 42.10%, (CI: 39.0, 45.21)), with hypertension (estimate- 41.76%, (CI: 38.99, 
44.54)), and income to poverty ratio < 1 (estimate- 40.68% (CI: 37.53, 43.83)) had 
significantly higher prevalence of family history of diabetes than those with more education, 
without hypertension, and income to poverty ratio ≥ 1 respectively.
The results from the polytomous logistic regression model to measure the association 
between the conditions, PD, UD, and DD, and reported family history of diabetes by treating 
those with none of these conditions as the referent group are given in Table 2. Among the 
entire U.S. population age ≥ 20 years, after controlling for all the other variables in the 
model, the prevalence ratios of DD, UD, and PD were 4.27 (CI: 3.57, 5.12), 2.03 (CI: 1.56, 
2.63), and 1.26 (CI: 1.09, 1.44) for those with a family history of diabetes compared to those 
without relative to those with none of these conditions. As expected, out of all the risk 
factors considered in the model, age group ≥ 60 years compared to age group 20-39 years 
had by far the highest adjusted prevalence ratios (DD-26.87, (CI: 19.39, 37.23), UD-16.33, 
(CI: 10.38, 25.68), and PD-5.11, (CI: 4.16, 6.28)). Those with BMI ≥ 30 kg/m2 and BMI 
25-30 kg/m2 had significantly higher prevalence ratios for all three conditions compared to 
those with BMI < 25 kg/m2 ((DD- 6.60, (CI: 5.31, 8.21), UD-8.19, (CI: 4.65, 14.41), and 
PD- 2.52, (CI: 1.99, 3.21)) and (DD- 1.93, (CI:1.55,2.41), UD- 2.02 (CI: 1.21, 3.37), and 
PD- 1.40, (CI: 1.13, 1.73)) respectively). Hispanic (DD- 1.89, (CI: 1.55, 2.30), UD- 2.22, 
(CI: 1.57, 3.15), and PD-1.23, (CI: 1.03, 1.47)), non-Hispanic black (DD-1.75, (CI: 1.42, 
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2.16), UD-1.98, (CI: 1.36, 2.87), and PD-1.42, (CI: 1.17, 1.74)), and other race/ ethnicity 
groups (DD- 3.34, (CI: 2.56, 4.34), UD- 4.24, (CI: 2.44, 7.38), PD- 1.47, (CI: 1.18, 1.85)) 
had significant prevalence ratios for all three conditions compared to the non-Hispanic white 
population. The adjusted prevalence ratio for DD was also significant for those with 
hypertension, with income to poverty ratio < 1, less than high school education, who were 
not physically active, and for males. Similarly, the prevalence ratio for UD was significant 
for those with hypertension, less than high school education, not physically active, and for 
males, and the prevalence ratio for PD was significant for those with hypertension, less than 
high school education, and for males.
Table 3 gives the prevalence of DD, UD, and PD, aORs and PAFs of reported family history 
of diabetes in the US population and population subgroups with risk factors considered in 
this study. Prevalence, aORs, and PAFs of UD are based on the population that does not have 
DD, and prevalence, aORs, and PAFs of PD are based on the population that does not have 
DD or UD.
The PAF for reported family history of diabetes for DD, UD, and PD in the US population 
were 48.66%, 20.59%, and 4.87% respectively. Among the population subgroups studied, 
the PAFs for family history of diabetes that were calculated with significant odds ratios 
ranged from 42.53% (age 20-39 years) to 60.17% (Hispanics) for DD, from 13.95% (age ≥ 
60 years) to 46.35% (other race/ethnicity) for UD, and from 3.93% (not physically active) to 
7.91% (females) for PD. The aORs between family history of diabetes and PD were not 
statistically significant for most population subgroups.
During 2009-2014, the average US population ≥ 20 years of age was 224.1 million. Using 
the prevalence estimates of DD (9.26%), UD (3.45%), and PD (40.55%), we found 20.7 
million, 7.0 million, and 79.6 million people had DD, UD, and PD, respectively in the US 
population. Of these, approximately 10.1 million cases (48.7%) with DD, 1.4 million cases 
(20.6%) with UD, and 3.9 million cases (4.9%) with PD were attributed to having a family 
history of diabetes (Table 3). Among the non-Hispanic white, non-Hispanic black, and 
Hispanic cases with DD, 5.6 million, 1.9 million, and 1.8 million, respectively were 
attributable to having a family history of diabetes: (Table 3). Similar results are given for 
population subgroups defined by other risk factor status, and for UD and PD.
Discussion
Our findings confirm the public health importance of family history as a risk factor 
associated with DD, UD, and PD. Given the high prevalence of reported family history and 
the high prevalence of diabetes and PD, our findings suggest that millions of people who 
have DD, UD, and PD in the United States can be identified using family history in first 
degree relatives. Among people 20 years and older in the US, 9.3% had DD, almost half of 
whom have their diabetes attributable to family history (burden of more than 10 million 
people). Around 3.4% of adults who were not diagnosed with diabetes had UD with more 
than 20% population attributable fraction for family history of diabetes (burden of more than 
1.4 million people). Finally, 40% of the population without diabetes had PD with 5% 
attributable to family history (burden of nearly 3.9 million people).
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These results show the burden of disease for DD, UD, and PD attributable to having a family 
history of diabetes. More than one third of the US population aged ≥ 20 years have family 
history of diabetes. In our analyses we found that approximately 13% of the US population 
in 2009-2014 had both family history of diabetes and PD (data not shown). Even though not 
everyone with PD will develop diabetes, it is possible, although still not established, that the 
risk of developing diabetes is higher for those with PD who also have family history of 
diabetes.
Based on the formula, the PAF declines sharply with the decline in adjusted prevalence ratio. 
The decline in PAF for DD, UD, and PD (48.7%, 20.6%, and 4.9% respectively) is due to 
the decline in adjusted odds ratios (3.6, 1.8, and 1.3 respectively). The magnitudes of the 
association of family history of diabetes with UD and PD are smaller than that for DD. A 
possible explanation for this is that people with diagnosed diabetes are more interested in 
knowing their family history of diabetes than those who are unaware of their disease status.7 
Similarly, the magnitudes of the significant associations of family history of diabetes with 
UD and PD were smaller than that for DD for population subgroups for the same reason. 
The PAFs for DD for most of the population subgroups remain close to the PAF for the 
overall population. Population subgroups, aged 20-39 and non-Hispanic white have 
somewhat smaller PAFs (42.5% and 44.5% respectively) whereas the minority populations 
have relatively larger PAFs (> 56%). Lack of significant associations between family history 
of diabetes and UD in a few population groups could be due to small sample sizes since the 
prevalence of UD was relatively low. However, there were several population subgroups 
without significant associations between family history of diabetes and PD even in groups 
with higher prevalence of PD. These findings are consistent with our statement above about 
the relationship between family history and awareness of disease. Awareness of PD is quite 
low in the U.S. population (<10% among persons with no family history of diabetes; 
10%-11% among those with family history of diabetes).22 Furthermore, it has been shown 
that with lower cut-off points for FPG and A1C levels for PD compared to previously used 
cut-off points, less than half the population diagnosed with PD are likely to develop diabetes 
in the next 10 years.23 There is also some concern that the same cut-off points should not be 
applied to different race/ ethnicity groups.23,24 Also, not everyone with PD develop 
diabetes23 and a more appropriate comparison group may be people with a family history of 
prediabetes. However, this information is not available in current surveys conducted in the 
United States.
Based on a genome-wide association study, several common genetic variants associated with 
type 2 diabetes were determined from different ancestral populations25. However, only 10% 
of the risk can be explained by these genetic variants.11 A recent study based on large scale 
sequencing also did not provide evidence that rare and low frequency variants increase the 
risk of type 2 diabetes.26 When considering prevention strategies for type 2 diabetes, it is 
important to stratify the population into groups by risk of developing type 2 diabetes. 
Genetic variants so far discovered do not seem to provide much further information in 
classifying those at increased risk of developing type 2 diabetes compared to traditional 
clinical risk factors. Even for genetic variants with higher relative risks in some ethnic 
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groups, it is recommended to consider traditional risk factors in combination with these 
genetic variants.27
Direct-to-consumer genetic testing companies make genetic tests available to predict risk of 
type 2 diabetes. Even without considering clinical validity and utility of these tests, these 
companies provide personalized genetic profiles, claiming that the genetic information 
received would persuade people at risk to implement healthier behaviors.28 However, based 
on a parallel group, open, randomized control trial to study the outcome of conveying an 
estimate of genetic or phenotypic risk of type 2 diabetes, researchers found that knowing a 
genetic or phenotypic risk estimate did not change behaviors when compared with standard 
lifestyle advice.28 On the other hand, a study based on a cluster-randomized clinical trial 
concluded that messages designed to target an individual's familial risk to six common 
diseases including diabetes moderately increased self-reported physical activity and intake 
of fruits and vegetables compared with a standard preventive message.29 Another recent 
study of non-diabetic patients randomized to counselling that included both family health 
history and genetic tests for type 2 diabetes found that family history was more highly 
associated with a perception of risk for type 2 diabetes than was genetic risk testing.30 These 
few studies suggest that knowledge of family history may be more likely to influence life 
style behaviors than knowledge based on genetic tests.
Study limitations
There are several limitations in our study. NHANES is a cross-sectional survey, and cannot 
be used to show causal effect of the risk factors on diabetes and PD we used in this study. 
However, these risk factors are well known in the literature, and thus in calculating impact 
numbers we assumed the causality of family history of diabetes on diabetes and PD. Also, 
DD was self- reported in the surveys and there could be differences in reporting bias 
between population groups. The data that NHANES collects do not allow us to differentiate 
between type 1 and type 2 diabetes, so our results are for diabetes overall, while 
interventions are based on evidence of risk reduction of type 2 diabetes. However, type 2 
diabetes accounts for about 95% of DD in U.S. adults.29 We also did not estimate the 
sampling errors of the impact numbers since the estimate of impact numbers includes the 
product of multiple estimates. The total of the impact numbers in demographic groups may 
not add up to the total for the US population. Moreover, the collection of family health 
history information is limited in NHANES. Participants were asked whether any of their first 
degree relatives were told by a health professional that they had diabetes. Since there is a 
high prevalence of UD in the population, it is likely that the prevalence of family history is 
under ascertained in the population and its relationship to the burden of diabetes in the 
population underestimated. There have been no population-based surveys that examined the 
accuracy of self-reported family histories of diabetes. However, based on data from 2004 
HealthStyles survey, the respondents' reported awareness of type 2 diabetes status of their 
first degree relatives was high, ranging from 87.8% to 94.5% depending on type of 
relationship.32 However, the differences in prevalence of reported family history between 
men and women suggest that there may be a recall or knowledge bias.7 Further information 
on family history of diabetes beyond first degree relatives is not available in NHANES 
2009-2014 to do a more comprehensive analysis of family history of diabetes.
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In spite of the recent interest and focus on genomics and precision medicine, family health 
history continues to be an integral component of public health campaigns to identify people 
at high risk for developing diabetes. Additional national efforts are needed, especially 
among high risk groups such as Hispanics, non-Hispanic blacks, and people with BMI ≥ 30 
kg/m2, to obtain information on family history that may contribute to reduction of incidence 
of type 2 diabetes, and early diagnosis of diabetes to help prevent or delay complications.
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Table 1
Crude prevalence of reported family history of diabetes by selected characteristics
Prevalence percent (95% CI) p-value
US population age 20 years and older
 Total 36.70 (35.05, 38.26)
Age (years)
 20-39 (1) 31.89 (29.48, 34.29)
 40-59 (2) 40.75 (38.28, 43.23)
 ≥60 (3) 37.28 (34.75, 39.81)
 Pairwise difference (1,2) < 0.001
 Pairwise difference (1,3) 0.001
 Pairwise difference (2,3) 0.049
Sex
 Males 34.47 (32.57, 36.36) < 0.001
 Females 38.72 (36.71, 40.73)
Race/ Ethnicity
 Non-Hispanic white (1) 33.61 (31.82, 35.40)
 Hispanic (2) 41.11 (37.68, 44.54)
 Non-Hispanic black (3) 48.92 (45.92, 51.91)
 Other* (4) 36.72 (32.28, 41.15)
 Pairwise difference (1,2) < 0.001
 Pairwise difference (1,3) < 0.001
 Pairwise difference (1,4) 0.157
 Pairwise difference (2,3) 0.002
 Pairwise difference (2,4) 0.128
 Pairwise difference (3,4) < 0.001
BMI (kg/m2)
 < 25 (1) 28.92 (26.11, 31.74)
 25-30 (2) 35.10 (33.09, 37.12)
 ≥ 30 (3) 44.30 (41.68, 46.92)
 Pairwise difference (1,2) < 0.001
 Pairwise difference (1,3) < 0.001
 Pairwise difference (2,3) < 0.001
Education
 < high school 42.10 (39.0, 45.21) < 0.001
 ≥ high school 35.51 (33.92, 37.11)
Income to poverty ratio
 < 1 40.68 (37.53, 43.83) 0.005
 ≥ 1 35.74 (33.95, 37.53)
Physically activity
 Not active 37.03 (35.18, 38.87) 0.376
 Active 35.50 (32.52, 38.49)
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Prevalence percent (95% CI) p-value
Hypertension
 Yes (1) 41.76 (38.99, 44.54) < 0.001
 No (2) 33.54 (31.57, 35.51)
*Non-Hispanic Asians, non-Hispanic multiracial, and non-Hispanic other race.
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Table 2
Estimates of prevalence ratios from polytomous logistic regression when populations 
having diagnosed diabetes (DD), undiagnosed diabetes (UD), and prediabetes (PD) were 
compared to the population not having any of these conditions
Prevalence Ratio Estimates (95% CI) by outcome
DD UD PD
Reported family history
 No†
 Yes 4.27 (3.57, 5.12) 2.03 (1.56, 2.63) 1.26 (1.09, 1.44)
Age (years)
 20-39†
 40-59 7.50 (5.56, 10.13) 5.93 (3.76, 9.35) 2.33 (1.97, 2.76)
 ≥60 26.87 (19.39, 37.23) 16.33 (10.38, 25.68) 5.11 (4.16, 6.28)
Sex
 Females†
 Males 1.96 (1.64, 2.34) 2.79 (2.06, 3.79) 1.61 (1.38, 1.88)
Race/ Ethnicity
 Non-Hispanic white†
 Hispanic 1.89 (1.55, 2.30) 2.22 (1.57, 3.15) 1.23 (1.03, 1.47)
 Non-Hispanic black 1.75 (1.42, 2.16) 1.98 (1.36, 2.87) 1.43 (1.17, 1.74)
 Other 3.34 (2.56, 4.34) 4.24 (2.44, 7.38) 1.47 (1.18, 1.85)
BMI (kg/m2)
 < 25†
 25-30 1.93 (1.55, 2.41) 2.02 (1.21, 3.37) 1.40 (1.13, 1.73)
 ≥ 30 6.60 (5.31, 8.21) 8.19 (4.65, 14.41) 2.52 (1.99, 3.21)
Income to poverty ratio
 ≥ 1†
 < 1 1.46 (1.14, 1.87) 1.24* (0.86, 1.79) 1.10* (0.91, 1.33)
Education
 ≥ high school†
 < high school 1.68 (1.40, 2.03) 1.87 (1.44, 2.43) 1.53 (1.25, 1.88)
Physically activity
 Active†
 Not active 1.37 (1.05, 1.80) 1.43 (1.01, 2.02) 0.91* (0.78, 1.08)
Hypertension
 No
 Yes 3.53 (2.76, 4.50) 1.99 (1.48, 2.66) 1.51 (1.22, 1.87)
†
Reference group
*
PRs are “not significant at 0.05 level”
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